Biomarkers in biliary atresia - an elusive promise of predicting outcome.
Where this comes from
- Record sourced from PubMed, PMID 39774329.
- Also identified by DOI 10.1038/s41390-024-03772-6 and PMC identifier 12119343.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Research on biomarkers in BA promises to predict and change outcomes in BA. This goal is still unrealized at the moment. The study by Kamp et al attempts to understand the drivers of fibrosis and elucidate the role of amyloid-related genes in the pathophysiology of BA. Based on this, they attempt to predict outcomes in BA using biomarkers by analysing plasma samples for amyloid precursor protein. There is a need to evaluate if shifting the focus from pre-KPE biomarkers to post-KPE biomarkers, serial evaluations and the use of composite scores could help in better prognostication.
Medical subject headings
- Biomarkers
- Biliary Atresia